EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mutation-based mechanism and evolution of the potent multidrug efflux pump RE-CmeABC in Campylobacter

Lei Dai, Zuowei Wu, Orhan Sahin, Shaohua Zhao, Edward W Yu iD, Qijing Zhang

Proceedings of the National Academy of Sciences · 17.12.2024 · 121 (51)

DOI: 10.1073/pnas.2415823121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 27.11.2024. Verfasst von Lei Dai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011. Hauptthemen laut MEDLINE: Campylobacter jejuni, Evolution, Molecular, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The resistance-nodulation-cell division (RND) superfamily of multidrug efflux systems are important players in mediating antibiotic resistance in gram-negative pathogens. Campylobacter jejuni , a major enteric pathogen, utilizes an RND-type transporter system, CmeABC, as the primary mechanism for extrusion of various antibiotics. Recently, a functionally potent variant of CmeABC (named RE-CmeABC) emerged in clinical Campylobacter isolates, conferring enhanced resistance to multiple antibiotic classes. Despite the clinical importance of RE-CmeABC, the molecular mechanisms for its functional gain and its evolutionary trajectory remain unknown. Here, we demonstrated that amino acid substitutions in RE-CmeB (inner membrane transporter), but not in RE-CmeA (periplasmic protein) and RE-CmeC (outer membrane protein), in conjunction with a nucleotide mutation in the promoter region of the efflux operon, are responsible for the functional gain of the multidrug efflux system. We also showed that RE- cmeABC is emerging globally and distributed in genetically diverse C. jejuni strains, suggesting its possible spread by horizontal gene transfer. Notably, many of RE- cmeABC harboring isolates were associated with the human host including strains from large disease outbreaks, indicating the clinical relevance and significance of RE-CmeABC. Evolutionary analysis indicated that RE- cmeB likely originated from Campylobacter coli , but its expansion mainly occurred in C. jejuni, possibly driven by antibiotic selection pressure. Additionally, RE- cmeB , but not RE- cmeA and RE- cmeC , experienced a selective sweep and was progressing to be fixed during evolution. Together, these results identify a mutation-based mechanism for functional gain in RE-CmeABC and reveal the key role of RE-CmeB in facilitating Campylobacter adaptation to antibiotic selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Campylobacter jejuniEvolution, MolecularDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsBacterial ProteinsMutationMembrane Transport ProteinsCampylobacterHumansCampylobacter InfectionsPromoter Regions, GeneticAmino Acid Substitution

Stichwörter der Autor:innen

Campylobacterantibiotic resistancegene editingmultidrug effluxpathogen evolution

Substanzen

Anti-Bacterial AgentsBacterial ProteinsMembrane Transport Proteins

Autor:innen und Institutionen

  • Department of Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011.
  • Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011.
  • Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, MD 20708.
  • Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106.

ORCID-Profile: Edward W Yu

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)

Zitieren

APA

Dai, L., Wu, Z., Sahin, O., Zhao, S., Yu, E. W., & Zhang, Q. (2024). Mutation-based mechanism and evolution of the potent multidrug efflux pump RE-CmeABC in Campylobacter. Proceedings of the National Academy of Sciences, 121(51). https://doi.org/10.1073/pnas.2415823121

Vancouver

Dai L, Wu Z, Sahin O, Zhao S, Yu EW, Zhang Q. Mutation-based mechanism and evolution of the potent multidrug efflux pump RE-CmeABC in Campylobacter. Proceedings of the National Academy of Sciences. 2024;121(51). doi:10.1073/pnas.2415823121

BibTeX
@article{Dai2024,
  author = {Dai, Lei and Wu, Zuowei and Sahin, Orhan and Zhao, Shaohua and Yu, Edward W and Zhang, Qijing},
  title = {Mutation-based mechanism and evolution of the potent multidrug efflux pump RE-CmeABC in Campylobacter},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {51},
  doi = {10.1073/pnas.2415823121}
}
Kostenlos starten →